Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH. Robbins DC, et al. Among authors: pagkalos em. Clin Ther. 2007 Nov;29(11):2349-64. doi: 10.1016/j.clinthera.2007.11.016. Clin Ther. 2007. PMID: 18158076 Clinical Trial.
Ambulatory blood pressure reduction after rosiglitazone treatment in patients with type 2 diabetes and hypertension correlates with insulin sensitivity increase.
Sarafidis PA, Lasaridis AN, Nilsson PM, Pagkalos EM, Hitoglou-Makedou AD, Pliakos CI, Kazakos KA, Yovos JG, Zebekakis PE, Tziolas IM, Tourkantonis AN. Sarafidis PA, et al. Among authors: pagkalos em. J Hypertens. 2004 Sep;22(9):1769-77. doi: 10.1097/00004872-200409000-00022. J Hypertens. 2004. PMID: 15311106 Clinical Trial.
Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE).
Mathieu C, Barnett AH, Brath H, Conget I, de Castro JJ, Göke R, Márquez Rodriguez E, Nilsson PM, Pagkalos E, Penfornis A, Schaper NC, Wangnoo SK, Kothny W, Bader G. Mathieu C, et al. Int J Clin Pract. 2013 Oct;67(10):947-56. doi: 10.1111/ijcp.12252. Epub 2013 Aug 21. Int J Clin Pract. 2013. PMID: 23961850 Free PMC article.
Influence of Supervised Disease Understanding and Diabetes Self-Management on Adherence to Oral Glucose-Lowering Treatment in Patients with Type 2 Diabetes.
Doupis J, Alexandrides T, Elisaf M, Melidonis A, Bousboulas S, Thanopoulou A, Pagkalos EM, Avramidis I, Pappas A, Arvaniti E, Karamousouli E, Voss B, Tentolouris N. Doupis J, et al. Among authors: pagkalos em. Diabetes Ther. 2019 Aug;10(4):1407-1422. doi: 10.1007/s13300-019-0648-9. Epub 2019 Jun 20. Diabetes Ther. 2019. PMID: 31222592 Free PMC article.
Real-World Adequacy of Glycaemic Control in Treatment-Naïve Greek Patients with Type 2 Diabetes Mellitus Initiating Treatment with Metformin Monotherapy at the Maximum Tolerated Dose: The Reload Study.
Tsimihodimos V, Bargiota A, Pagkalos EM, Manes C, Papas A, Karamousouli E, Voss B, Elisaf MS. Tsimihodimos V, et al. Among authors: pagkalos em. Exp Clin Endocrinol Diabetes. 2020 Apr;128(4):224-230. doi: 10.1055/a-0824-6607. Epub 2019 Jan 22. Exp Clin Endocrinol Diabetes. 2020. PMID: 30669167